Immunohistochemical and quantitative competitive PCR analyses of midkine and pleiotrophin expression in cervical cancer.
暂无分享,去创建一个
Hye-Sung Moon | H. Chung | Won I Park | Sun Hee Sung | Eun-Ah Choi | Hye-Won Chung | Bock Hi Woo | S. Sung | E. Choi | H. Moon | B. Woo | W. Park
[1] T. Deuel,et al. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Jaye,et al. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. , 1994, Growth factors.
[3] M. Wick,et al. Midkine and pleiotrophin expression in normal and malignant breast tissue , 1994, Cancer.
[4] T. Muramatsu,et al. Expression of Midkine and Pleiotropin in Ovarian Tumors , 1997, Obstetrics and gynecology.
[5] S. Donnini,et al. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. , 1997, Cancer research.
[6] S. Takao,et al. Increased Midkine Gene Expression in Human Gastrointestinal Cancers , 1995, Japanese journal of cancer research : Gann.
[7] M. Noda,et al. Levels of expression of pleiotrophin and protein tyrosine phosphatase zeta are decreased in human colorectal cancers. , 1998, Cancer letters.
[8] A. Harris,et al. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. , 1996, Cancer research.
[9] M. Noda,et al. Haptotactic Migration Induced by Midkine , 2001, The Journal of Biological Chemistry.
[10] Seung Cheol Kim,et al. Concentration of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1) in the serum of patients with cervical cancer: prediction of response. , 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[11] Michael Cross,et al. Growth factors in development, transformation, and tumorigenesis , 1991, Cell.
[12] T. Deuel,et al. Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. , 1999, Current opinion in hematology.
[13] A. Wellstein,et al. Pleiotrophin and midkine in normal development and tumor biology. , 1995, Critical reviews in oncogenesis.
[14] M. Matsuyama,et al. Expression of midkine in the early stage of carcinogenesis in human colorectal cancer , 1999, British Journal of Cancer.
[15] M. Watson,et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. , 1990, Science.
[16] C. Lowenstein,et al. Midkine Induces Tumor Cell Proliferation and Binds to a High Affinity Signaling Receptor Associated with JAK Tyrosine Kinases* , 1998, The Journal of Biological Chemistry.
[17] T. Shintani,et al. 6B4 Proteoglycan/Phosphacan, an Extracellular Variant of Receptor-like Protein-tyrosine Phosphatase ζ/RPTPβ, Binds Pleiotrophin/Heparin-binding Growth-associated Molecule (HB-GAM)* , 1996, The Journal of Biological Chemistry.
[18] T. Muramatsu,et al. Midkine induces the transformation of NIH3T3 cells. , 1997, British Journal of Cancer.
[19] M. Noda,et al. Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase β/ζ , 2000 .
[20] Y. Wen,et al. Interleukin-1β Regulates Urokinase Plasminogen Activator (u-PA), u-PA Receptor, Soluble u-PA Receptor, and Plasminogen Activator Inhibitor-1 Messenger Ribonucleic Acid Expression in Cultured Human Endometrial Stromal Cells1 , 2001 .
[21] S. Natsugoe,et al. Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas. , 1998, British Journal of Cancer.
[22] A. Wellstein,et al. Signal Transduction Pathways Involved in the Mitogenic Activity of Pleiotrophin , 1997, Journal of Biological Chemistry.
[23] D. Wen,et al. Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin* , 2001, The Journal of Biological Chemistry.
[24] H. Chung,et al. Expression and Tyrosine Phosphorylation of E-Cadherin, β- and γ-Catenin, and Epidermal Growth Factor Receptor in Cervical Cancer Cells☆ , 2001 .
[25] H. Rauvala,et al. Molecular cloning of the 18-kDa growth-associated protein of developing brain. , 1990, The Journal of biological chemistry.
[26] A. Nakagawara,et al. A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. , 1993, Cancer research.